BIOMARQUEURS POUR LES CANCERS RÉAGISSANT AUX MODULATEURS DE L'ACTIVITÉ HEC1

• 收藏
• 分享

专利权人:

TAIVEX THERAPEUTICS CORPORATION

发明人:

HUANG, YU-LING,LAU, JOHNSON

申请号：

EP12851702

公开号：

EP2783217A4

申请日:

2012.11.19

申请国别(地区):

EP

年份:

2015

代理人:

摘要：

Contemplated compositions and methods are drawn to biomarkers and methods related to treatment of neoplastic disease with Hec1 inhibitor. Gene status and/or expression levels of Hec1(HEC), Rb(RB1), and/or p53 (TP53) may be useful as biomarkers for sensitivity to treatment with a Hec1 inhibitor. In addition, Hec 1 inhibitors may show synergistic effects when used in conjunction with cytotoxic drugs.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/